“…Some scientific researchers reported that APWS patients responded more favorably to PDL therapy, and required fewer treatments than those with CPWS 1,2 . They proposed telangiectatic nature, relatively sparse number and superficial location of ectatic vessels as a cause of ; however, at the same time, poor results in several patients were also reported by some authors 1,2 . Generally, pathological parameters like vessel diameter, depth, and luminal erythrocytes contents were provided as evidence that could explain the difference in therapeutic outcome [7][8][9] .…”